--- schema_version: "secwatch.filing_event.v1" accession: "0001193125-24-068672" form_type: "8-K" ticker: null cik: "0001832415" company_name: "Better Therapeutics, Inc." filed_at: "2024-03-15T23:59:59+00:00" generated_at: "2026-06-04T17:48:29.310456+00:00" event_type: "other_material" sentiment: "negative" materiality_score: 1.0 calibrated_materiality_score: 1.0 confidence: "high" source: SEC EDGAR --- # Better Therapeutics voluntarily delists from Nasdaq, entire board and top officers replaced by wind-down specialist ## Summary - Nasdaq hearing March 14 led to voluntary delisting; trading suspended March 18, 2024. - All seven directors resigned, including Chairman Frank Karbe, and CEO Karbe stepped down. - CMO Dr. Mark Berman and CPO Kristyn Wynholds terminated from positions. - Craig R. Jalbert appointed sole officer and director; annual compensation $33,333. - Company intends to file Form 15 to suspend SEC reporting obligations. ## SEC filing metadata - accession: 0001193125-24-068672 - form_type: 8-K - cik: 0001832415 - company_name: Better Therapeutics, Inc. - filed_at: 2024-03-15T23:59:59+00:00 - event_type: other_material - sentiment: negative - materiality_score: 1.0 - calibrated_materiality_score: 1.0 - confidence: high - sec_items: 3.01, 5.02 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1832415/000119312524068672/0001193125-24-068672-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832415/000119312524068672/d812144d8k.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001193125-24-068672 - JSON: https://secwatch.observer/filing/0001193125-24-068672.json - Plain text: https://secwatch.observer/filing/0001193125-24-068672.txt ## Key facts - Executive change Dr. Risa Lavizzo-Mourey resigned as Director at Better Therapeutics, Inc.. - Action: resigned - Role: Director source text: On March 14, 2024, Frank Karbe, David Perry, Andrew Armanino, Geoffrey Parker, Dr. Elder Granger, Dr. Risa Lavizzo-Mourey and Dr. Richard Carmona each notified the Company of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof. evidence_url: https://www.sec.gov/Archives/edgar/data/1832415/000119312524068672/0001193125-24-068672-index.htm - Executive change Dr. Richard Carmona resigned as Director at Better Therapeutics, Inc.. - Action: resigned - Role: Director source text: On March 14, 2024, Frank Karbe, David Perry, Andrew Armanino, Geoffrey Parker, Dr. Elder Granger, Dr. Risa Lavizzo-Mourey and Dr. Richard Carmona each notified the Company of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof. evidence_url: https://www.sec.gov/Archives/edgar/data/1832415/000119312524068672/0001193125-24-068672-index.htm - Executive change Kristyn Wynholds was terminated as Chief Product Officer at Better Therapeutics, Inc.. - Action: terminated - Role: Chief Product Officer source text: On March 14, 2024, Dr. Mark Berman and Kristyn Wynholds were each notified by the Company of termination of their positions as Chief Medical Officer and Chief Product Officer, respectively. evidence_url: https://www.sec.gov/Archives/edgar/data/1832415/000119312524068672/0001193125-24-068672-index.htm - Executive change Geoffrey Parker resigned as Director at Better Therapeutics, Inc.. - Action: resigned - Role: Director source text: On March 14, 2024, Frank Karbe, David Perry, Andrew Armanino, Geoffrey Parker, Dr. Elder Granger, Dr. Risa Lavizzo-Mourey and Dr. Richard Carmona each notified the Company of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof. evidence_url: https://www.sec.gov/Archives/edgar/data/1832415/000119312524068672/0001193125-24-068672-index.htm - Executive change Dr. Mark Berman was terminated as Chief Medical Officer at Better Therapeutics, Inc.. - Action: terminated - Role: Chief Medical Officer source text: On March 14, 2024, Dr. Mark Berman and Kristyn Wynholds were each notified by the Company of termination of their positions as Chief Medical Officer and Chief Product Officer, respectively. evidence_url: https://www.sec.gov/Archives/edgar/data/1832415/000119312524068672/0001193125-24-068672-index.htm - Executive change Andrew Armanino resigned as Director at Better Therapeutics, Inc.. - Action: resigned - Role: Director source text: On March 14, 2024, Frank Karbe, David Perry, Andrew Armanino, Geoffrey Parker, Dr. Elder Granger, Dr. Risa Lavizzo-Mourey and Dr. Richard Carmona each notified the Company of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof. evidence_url: https://www.sec.gov/Archives/edgar/data/1832415/000119312524068672/0001193125-24-068672-index.htm - Executive change Craig R. Jalbert was appointed as Director at Better Therapeutics, Inc.. - Action: appointed - Role: Director source text: On March 14, 2024, the Board appointed Craig R. Jalbert, age 61, as the Company’s CEO, President, Treasurer, Secretary, and sole member of the Board. evidence_url: https://www.sec.gov/Archives/edgar/data/1832415/000119312524068672/0001193125-24-068672-index.htm - Executive change Frank Karbe resigned as CEO, President, Treasurer and Secretary at Better Therapeutics, Inc.. - Action: resigned - Role: CEO, President, Treasurer and Secretary source text: On March 14, 2024, Frank Karbe resigned from his position as CEO, President, Treasurer and Secretary. evidence_url: https://www.sec.gov/Archives/edgar/data/1832415/000119312524068672/0001193125-24-068672-index.htm - Executive change David Perry resigned as Director at Better Therapeutics, Inc.. - Action: resigned - Role: Director source text: On March 14, 2024, Frank Karbe, David Perry, Andrew Armanino, Geoffrey Parker, Dr. Elder Granger, Dr. Risa Lavizzo-Mourey and Dr. Richard Carmona each notified the Company of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof. evidence_url: https://www.sec.gov/Archives/edgar/data/1832415/000119312524068672/0001193125-24-068672-index.htm - Executive change Dr. Elder Granger resigned as Director at Better Therapeutics, Inc.. - Action: resigned - Role: Director source text: On March 14, 2024, Frank Karbe, David Perry, Andrew Armanino, Geoffrey Parker, Dr. Elder Granger, Dr. Risa Lavizzo-Mourey and Dr. Richard Carmona each notified the Company of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof. evidence_url: https://www.sec.gov/Archives/edgar/data/1832415/000119312524068672/0001193125-24-068672-index.htm - Executive change Craig R. Jalbert was appointed as CEO, President, Treasurer, Secretary at Better Therapeutics, Inc.. - Action: appointed - Role: CEO, President, Treasurer, Secretary source text: On March 14, 2024, the Board appointed Craig R. Jalbert, age 61, as the Company’s CEO, President, Treasurer, Secretary, and sole member of the Board. evidence_url: https://www.sec.gov/Archives/edgar/data/1832415/000119312524068672/0001193125-24-068672-index.htm - Executive change Frank Karbe resigned as Director at Better Therapeutics, Inc.. - Action: resigned - Role: Director source text: On March 14, 2024, Frank Karbe, David Perry, Andrew Armanino, Geoffrey Parker, Dr. Elder Granger, Dr. Risa Lavizzo-Mourey and Dr. Richard Carmona each notified the Company of their respective resignations as members of the Company’s board of directors (the “Board”) and all committees thereof. evidence_url: https://www.sec.gov/Archives/edgar/data/1832415/000119312524068672/0001193125-24-068672-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.